Rare diseases
Investigational molecules
Locations
290 conditions with trials, the busiest first
1 641 trials across Europe, recruiting first
Study of ritlecitinib for treating severe alopecia areata in children aged 6 to under 12 years
CzechiaStudy of SAR442970 to treat moderate to severe ulcerative colitis in adults
CzechiaStudy of AMG 732 injection compared to placebo in patients with moderate to severe thyroid eye disease
FranceStudy of VRDN-001 compared to placebo to evaluate safety and effectiveness in adults with chronic thyroid eye disease
FranceStudy of efavaleukin alfa safety and effectiveness in adults with moderate to severe ulcerative colitis
AustriaStudy of Efavaleukin Alfa to Treat Adults with Moderate to Severe Ulcerative Colitis
AustriaStudy of SAR441566 and methotrexate in adults with moderate to severe rheumatoid arthritis
CzechiaLong-term safety study of NNC6019-0001 for patients with transthyretin amyloid cardiomyopathy (ATTR-CM)
CzechiaStudy of Descartes-08 compared to placebo in adults with generalized myasthenia gravis
ItalyStudy of BLU-808 tablets compared to placebo in adults with chronic inducible urticaria and chronic spontaneous urticaria
DenmarkComparing weekly insulin icodec and daily insulin glargine with insulin aspart in adults with type 1 diabetes: a 26-week study of blood sugar control
GermanyStudy of Lepidoglyphus destructor allergen extract using skin prick tests in patients with allergies
SpainThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
